Textbook of Uncommon Cancer
450,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
225 °P sammeln
  • Gebundenes Buch

An uncommon tumor presents a difficult challenge to the clinician as advice on diagnosis, treatment, and therapy is scarce. Rather than spend extended periods of time researching each new presentation of an uncommon cancer, the Textbook of Uncommon Cancer provides the clinician with all the information and advice needed in one comprehensive guide. The fifth edition of this authoritative and unique text has been fully revised with new material and an evidence-based, teach-by-example approach in order to deliver unparalleled insight on real-world decision-making in the clinical setting. Where…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
An uncommon tumor presents a difficult challenge to the clinician as advice on diagnosis, treatment, and therapy is scarce. Rather than spend extended periods of time researching each new presentation of an uncommon cancer, the Textbook of Uncommon Cancer provides the clinician with all the information and advice needed in one comprehensive guide. The fifth edition of this authoritative and unique text has been fully revised with new material and an evidence-based, teach-by-example approach in order to deliver unparalleled insight on real-world decision-making in the clinical setting. Where evidence is scarce, the authors provide paradigms on how they address the relevant issues from first principles. Contributions are made by highly experienced and senior teams of medical oncologists, radiation oncologists, and other specialists, giving a balanced and complete overview on how to address each malignancy. New to this edition are the following: - An increased focus on gene expressions to refine diagnosis. - The inclusion of heat maps to show this gene expression. - An increased focus on explaining histopathology. Textbook of Uncommon Cancer enables readers to improve their quality of care by providing expert collation of limited evidence-based and clinical data. Beautifully designed with full color throughout, this is the ideal resource for the clinician inexperienced in treating rare tumors.
Autorenporträt
The editors Derek Raghavan, MD, PhD, FACP, FRACP, FASCO. President, Levine Cancer Institute, Carolinas HealthCare System; Professor of Medicine, University of North Carolina School of Medicine, Charlotte, North Carolina, USA. Manmeet S. Ahluwalia, MD, FACP. Dean and Diane Miller Family Endowed Chair in Neuro-Oncology, Head of Operations, Director, Brain Metastasis Research Program; Associate Director, Clinical Trials, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic; Associate Professor, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA. Charles D. Blanke, MD, FACP, FASCO. Professor of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, Oregon, USA. Jubilee Brown, MD. Professor and Associate Director of Gynecologic Oncology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA Edward S. Kim, MD, FACP. Chair, Department of Solid Tumor Oncology and Investigational Therapeutics; Donald S. Kim Distinguished Chair for Cancer Research, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA. Gregory H. Reaman, MD. Professor of Pediatrics, George Washington University School of Medicine and Health Sciences; Center for Cancer and Blood Disorders, Children's National Health System, Washington, District of Columbia, USA. Mikkael A. Sekeres, MD, MS. Director, Leukemia Program and Professor of Medicine, Cleveland Clinic, Cleveland, Ohio, USA.